Table 2.
Expression of Novel ebv-miRNA and LMP2A in NPC Samples.
| Sample | BART21 | BART22 | LMP2A mRNA* | LMP2A IHC† |
| C666-1 | 100 | 100 | 100 | - |
| NPC1 | 9.17 | 36.39 | <1 | - |
| NPC2 | 52.57 | 123.18 | 226 | - |
| NPC3 | 31.85 | 41.07 | 242 | - |
| NPC4 | 26.97 | 18.85 | 258 | - |
| NPC5 | 47.44 | 76.54 | 257 | - |
| NPC6 | 3.15 | 2.06 | <1 | + |
| NPC7 | 29.36 | 39.17 | 233 | - |
| NPC8 | 25.81 | 28.05 | 335 | + |
| NPC9 | 8.71 | 30.68 | 264 | - |
| NPC10 | 61.72 | 64.04 | NA | - |
| NPC11 | 12 | 55.2 | 183 | + |
| NP1 | 0 | 0 | 0 | - |
| NP2 | 0 | 0 | 0 | - |
| NP3 | 0 | 0 | 0 | - |
Expression level of C666-1 was set at 100.
NA indicates not analyzed.
*
Expression level was normalized to EBNA1.
†
LMP2A-negative (-) or-positive (+) were indicated.